Corteva products developed using CRISPR-Cas advanced plant breeding only include genetic material from the target plant/crop.
Corteva is committed to open, transparent and timely communications about its use of CRISPR-Cas.
Corteva is committed to the responsible development and application of CRISPR-Cas to help ensure consumer confidence.
Corteva supports appropriate, science-based regulatory oversight for plants developed with CRISPR-Cas advanced plant breeding, consistent with plants developed through other plant breeding methods.
Corteva intends to enable others wanting to develop agricultural products using CRISPR-Cas through access to intellectual property (IP), technology capabilities, infrastructure and scientific expertise.
Corteva will engage those with diverse viewpoints to inform its decision-making process for products developed with CRISPR-Cas advanced plant breeding.
1“CRISPR-Cas” is derived from naturally occurring “CRISPR” found in many bacteria that protect themselves against bacteriophage. Corteva Agriscience has used CRISPR for many years to improve dairy product manufacturing and to make food safe and last longer.
2These principles refer to the Corteva Agriscience use of “CRISPR-Cas” as a plant breeding technique. If CRISPR-Cas is used to more efficiently develop GMOs, Corteva Agriscience will follow all applicable GMO regulations and the DuPont Biotechnology Guiding Principles. See more here.
Last updated: November 8, 2018
Collaborating for the Greater Good
We welcome the opportunity to collaborate with others to realize the full potential of CRISPR-Cas for agriculture across all crops and geographies.
Our first project will apply CRISPR-Cas to address maize lethal necrosis disease in Sub-Saharan Africa. This disease has reduced maize production on some farms by up to 90 percent. CRISPR-Cas has the ability to provide climate- and disease-resilient corn varieties to the farmers who need them.